Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

A model of skin inflammation in humans leads to a rapid and reproducible increase in the interferon response signature: a potential translational model for drug development.

Dickson MC, Ludbrook VJ, Perry HC, Wilson PA, Garthside SJ, Binks MH.

Inflamm Res. 2015 Apr;64(3-4):171-83. doi: 10.1007/s00011-015-0795-z. Epub 2015 Jan 18.

PMID:
25596950
2.

The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.

Cambridge G, Perry HC, Nogueira L, Serre G, Parsons HM, De La Torre I, Dickson MC, Leandro MJ, Edwards JC.

J Autoimmun. 2014 May;50:67-76. doi: 10.1016/j.jaut.2013.12.002. Epub 2013 Dec 22.

PMID:
24365380
3.

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag.

Casimiro DR, Wang F, Schleif WA, Liang X, Zhang ZQ, Tobery TW, Davies ME, McDermott AB, O'Connor DH, Fridman A, Bagchi A, Tussey LG, Bett AJ, Finnefrock AC, Fu TM, Tang A, Wilson KA, Chen M, Perry HC, Heidecker GJ, Freed DC, Carella A, Punt KS, Sykes KJ, Huang L, Ausensi VI, Bachinsky M, Sadasivan-Nair U, Watkins DI, Emini EA, Shiver JW.

J Virol. 2005 Dec;79(24):15547-55.

4.

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.

Fan J, Liang X, Horton MS, Perry HC, Citron MP, Heidecker GJ, Fu TM, Joyce J, Przysiecki CT, Keller PM, Garsky VM, Ionescu R, Rippeon Y, Shi L, Chastain MA, Condra JH, Davies ME, Liao J, Emini EA, Shiver JW.

Vaccine. 2004 Aug 13;22(23-24):2993-3003.

PMID:
15297047
5.

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines.

Aste-Am├ęzaga M, Bett AJ, Wang F, Casimiro DR, Antonello JM, Patel DK, Dell EC, Franlin LL, Dougherty NM, Bennett PS, Perry HC, Davies ME, Shiver JW, Keller PM, Yeager MD.

Hum Gene Ther. 2004 Mar;15(3):293-304.

PMID:
15018738
6.

Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.

Casimiro DR, Chen L, Fu TM, Evans RK, Caulfield MJ, Davies ME, Tang A, Chen M, Huang L, Harris V, Freed DC, Wilson KA, Dubey S, Zhu DM, Nawrocki D, Mach H, Troutman R, Isopi L, Williams D, Hurni W, Xu Z, Smith JG, Wang S, Liu X, Guan L, Long R, Trigona W, Heidecker GJ, Perry HC, Persaud N, Toner TJ, Su Q, Liang X, Youil R, Chastain M, Bett AJ, Volkin DB, Emini EA, Shiver JW.

J Virol. 2003 Jun;77(11):6305-13.

7.

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA.

Nature. 2002 Jan 17;415(6869):331-5.

PMID:
11797011
8.

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.

Barouch DH, Santra S, Tenner-Racz K, Racz P, Kuroda MJ, Schmitz JE, Jackson SS, Lifton MA, Freed DC, Perry HC, Davies ME, Shiver JW, Letvin NL.

J Immunol. 2002 Jan 15;168(2):562-8.

9.

Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene.

Casimiro DR, Tang A, Perry HC, Long RS, Chen M, Heidecker GJ, Davies ME, Freed DC, Persaud NV, Dubey S, Smith JG, Havlir D, Richman D, Chastain MA, Simon AJ, Fu TM, Emini EA, Shiver JW.

J Virol. 2002 Jan;76(1):185-94.

10.

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.

Barouch DH, Craiu A, Kuroda MJ, Schmitz JE, Zheng XX, Santra S, Frost JD, Krivulka GR, Lifton MA, Crabbs CL, Heidecker G, Perry HC, Davies ME, Xie H, Nickerson CE, Steenbeke TD, Lord CI, Montefiori DC, Strom TB, Shiver JW, Lewis MG, Letvin NL.

Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4192-7.

11.

Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration.

Barouch DH, Santra S, Steenbeke TD, Zheng XX, Perry HC, Davies ME, Freed DC, Craiu A, Strom TB, Shiver JW, Letvin NL.

J Immunol. 1998 Aug 15;161(4):1875-82.

12.

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination.

Letvin NL, Montefiori DC, Yasutomi Y, Perry HC, Davies ME, Lekutis C, Alroy M, Freed DC, Lord CI, Handt LK, Liu MA, Shiver JW.

Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9378-83.

13.

Anti-HIV env immunities elicited by nucleic acid vaccines.

Shiver JW, Davies ME, Yasutomi Y, Perry HC, Freed DC, Letvin NL, Liu MA.

Vaccine. 1997 Jun;15(8):884-7.

PMID:
9234539
14.

Humoral and cellular immunities elicited by HIV-1 vaccination.

Shiver JW, Davies ME, Perry HC, Freed DC, Liu MA.

J Pharm Sci. 1996 Dec;85(12):1317-24.

PMID:
8961146
15.

Vaccination of mice and nonhuman primates using HIV-gene-containing DNA.

Liu MA, Yasutomi Y, Davies ME, Perry HC, Freed DC, Letvin NL, Shiver JW.

Antibiot Chemother (1971). 1996;48:100-4. No abstract available.

PMID:
8726511
16.

Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination.

Shiver JW, Perry HC, Davies ME, Freed DC, Liu MA.

Ann N Y Acad Sci. 1995 Nov 27;772:198-208.

PMID:
8546393
17.

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

Montgomery DL, Shiver JW, Leander KR, Perry HC, Friedman A, Martinez D, Ulmer JB, Donnelly JJ, Liu MA.

DNA Cell Biol. 1993 Nov;12(9):777-83.

PMID:
8216848
18.
20.

Characterization of the herpes simplex virus origin binding protein interaction with OriS.

Hazuda DJ, Perry HC, Naylor AM, McClements WL.

J Biol Chem. 1991 Dec 25;266(36):24621-6.

21.

Synthesis and antiherpetic activity of (+/-)-9-[[(Z)-2-(hydroxymethyl)cyclopropyl]methyl]guanine and related compounds.

Ashton WT, Meurer LC, Cantone CL, Field AK, Hannah J, Karkas JD, Liou R, Patel GF, Perry HC, Wagner AF, et al.

J Med Chem. 1988 Dec;31(12):2304-15.

PMID:
2848125
22.
23.

Receivables: a primer for trustees.

Perry HC.

Trustee. 1988 Apr;41(4):20. No abstract available.

PMID:
10286722
24.

Analyze your cash-flow position.

Perry HC.

Trustee. 1987 Oct;40(10):16. No abstract available.

PMID:
10284770
25.

Efficacy of 2'-nor-cyclicGMP in treatment of experimental herpes virus infections.

Field AK, Davies ME, DeWitt CM, Perry HC, Schofield TL, Karkas JD, Germershausen J, Wagner AF, Cantone CL, MacCoss M, et al.

Antiviral Res. 1986 Oct;6(6):329-41.

PMID:
3022643
26.

Synthesis and antiherpetic activity of (S)-, (R)-, and (+/-)-9-[(2,3-dihydroxy-1-propoxy)methyl]guanine, linear isomers of 2'-nor-2'-deoxyguanosine.

Ashton WT, Canning LF, Reynolds GF, Tolman RL, Karkas JD, Liou R, Davies ME, DeWitt CM, Perry HC, Field AK.

J Med Chem. 1985 Jul;28(7):926-33.

PMID:
2989523
27.

Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication.

Tocci MJ, Livelli TJ, Perry HC, Crumpacker CS, Field AK.

Antimicrob Agents Chemother. 1984 Feb;25(2):247-52.

28.

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.

Field AK, Davies ME, DeWitt C, Perry HC, Liou R, Germershausen J, Karkas JD, Ashton WT, Johnston DB, Tolman RL.

Proc Natl Acad Sci U S A. 1983 Jul;80(13):4139-43.

29.

The financial impact of Medicare, Medicaid losses.

Perry HC.

Trustee. 1982 Jun;35(6):36, 38. No abstract available.

PMID:
10298572
30.

Sizing up your hospital's financial performance.

Perry HC.

Trustee. 1981 Jun;34(6):20, 22. No abstract available.

PMID:
10251661
31.

A/R investment resembles fixed asset.

Perry HC.

Hosp Financ Manage. 1979 Sep;33(9):8. No abstract available.

PMID:
10243112
32.

Spindle cell sarcoma of the vagina; a case treated by radium implant.

STRICKLAND P, PERRY HC.

J Obstet Gynaecol Br Emp. 1956 Apr;63(2):280-1. No abstract available.

PMID:
13320234

Supplemental Content

Loading ...
Support Center